Want to see AZR full AI Analyst Report?
Azora Therapeutics (AZR) Financial Statements
Azora Therapeutics Financial Overview
Azora Therapeutics's market cap is currently $10.00M. The company's EPS TTM is $-16.53; its P/E ratio is -0.30; Azora Therapeutics has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Mar 24 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ -564.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -7.80M | $ -8.28M | $ -6.89M | $ -10.86M | $ -19.29M |
| EBITDA | $ -7.98M | $ -13.20M | $ -7.00M | $ -10.80M | $ -17.69M |
| Net Income | $ -7.98M | $ -13.20M | $ -7.00M | $ -12.73M | $ -19.42M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 5.88M | $ 3.75M | $ 2.83M | $ 4.00M | $ 6.06M |
| Total Assets | $ 6.80M | $ 5.04M | $ 4.74M | $ 5.73M | $ 7.63M |
| Total Debt | $ 0.00 | $ 0.00 | $ 0.00 | $ 207.38K | $ 256.96K |
| Net Debt | $ -5.88M | $ -3.75M | $ -2.83M | $ -3.79M | $ -5.81M |
| Total Liabilities | $ 1.52M | $ 975.86K | $ 653.51K | $ 2.46M | $ 4.13M |
| Stockholders' Equity | $ 5.28M | $ 4.07M | $ 4.08M | $ 3.28M | $ 3.51M |
| Cash Flow | |||||
| Free Cash Flow | $ -6.49M | $ -6.92M | $ 0.00 | $ -11.19M | $ -12.01M |
| Operating Cash Flow | $ -6.49M | $ -6.92M | $ -6.81M | $ -11.19M | $ -11.95M |
| Investing Cash Flow | $ 150.00K | $ 0.00 | $ 1.50M | $ 0.00 | $ -34.02K |
| Financing Cash Flow | $ 8.47M | $ 7.85M | $ 4.13M | $ 9.13M | $ 13.64M |
Currency in USD